Mexico vs Romania: The number of people with susceptibility test result for rifampicin
Mexico
4,205
in 2021
Romania
4,366
in 2021
Mexico rank
34th
Romania rank
31st
The number of people with susceptibility test result for rifampicin over time
- Mexico
- Romania
How they compare
Romania currently reports 4,366 against 4,205 in Mexico, a difference of 161.
Across all 5 years both countries report, Romania has been ahead every year.
Mexico ranks 34th and Romania ranks 31st of 155 countries.
Romania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mexico | Romania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 183.67 | 6,018 | 5,834 | Romania |
| 2020s | 3,240 | 3,988 | 747.5 | Romania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mexico or Romania?
- Romania, at 4,366 against 4,205 in Mexico as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mexico and Romania?
- 161, with Romania ahead.
- How many years of comparable data are there for Mexico and Romania?
- 5 years are reported by both, from 2017 to 2021.
- How do Mexico and Romania rank globally for the number of people with susceptibility test result for rifampicin?
- Mexico ranks 34th and Romania ranks 31st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.